Singapore-based biopharmaceutical company Specialised Therapeutics (ST) has announced the Australian registration of SKY...
Nuclera, a UK-based biotechnology company accelerating protein expression and optimisation through its benchtop eProtein...
Cellares, a pioneer in automated cell therapy manufacturing, in collaboration with Mitsui Fudosan, has announced the est...
Australia-based IonOpticks, developer of chromatography columns for mass spectrometry research, has announced the l...
Taiwan-based Formosa Pharmaceuticals has entered into an exclusive licensing agreement with Adalvo Limited in the Europe...
ICPI Week 2025 Wrap-Up ICPI WEEK 2025 WRAP-UP | BY MANBEENA CHAWLA, EXECUTIVE EDITOR, BIOSPECTRUM ASIA ...
Eli Lilly and Company has announced that the Australian Therapeutic Goods Administration (TGA) has granted marketing aut...
Ireland-headquartered Medtronic plc, a global leader in healthcare technology, has announced its intent to separate its ...
Australia-based Kailo Medical, a global leader in structured reporting for medical imaging, has announced its acquisitio...
Pfizer Inc. has entered into an exclusive global, ex-China, licensing agreement with 3SBio, Inc., a leading Chinese biop...
RevolKa Ltd., a venture-backed biotech company providing a cutting-edge artificial intelligence (AI)-driven protein engi...
In a groundbreaking move, Gene Solutions, a leader in prenatal and oncology genetic testing, and NEWCL Biomedical Labora...
China-based Viva Biotech recently held the AIDD platform launch event "Enchantment of Drug Discovery," unveiling the adv...
Rznomics Inc., a South Korea-based biopharmaceutical startup specialising in RNA-based therapeutics, has entered in...
Patients with non-proliferative diabetic retinopathy (NPDR) currently face a therapeutic gap—one that often leaves...
US-based Sarepta Therapeutics, Inc. has announced that the Japanese Ministry of Health, Labour, and Welfare (MHLW) has a...
Minghui Pharmaceutical, a late-stage clinical biopharmaceutical company, has announced an exclusive licensing and collab...
UK-based Aptamer Group plc, the leading developer of next-generation synthetic binders delivering innovation to the life...
